UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057261
Receipt number R000065354
Scientific Title Efficacy of Rikkunshito in preoperative patients with urological cancer
Date of disclosure of the study information 2025/03/11
Last modified on 2025/09/10 10:18:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Rikkunshito in preoperative patients with urological cancer

Acronym

Efficacy of Rikkunshito in preoperative patients with urological cancer

Scientific Title

Efficacy of Rikkunshito in preoperative patients with urological cancer

Scientific Title:Acronym

Efficacy of Rikkunshito in preoperative patients with urological cancer

Region

Japan


Condition

Condition

Urological cancer patients before surgery

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To verify the usefulness of Rikkunshito in patients undergoing surgery for urological cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

Changes in EuroQol-5 and Dimension-5 scores

Key secondary outcomes

Frequency of perioperative complications
Change in Controlling Nutrition Score
Change in Mini Nutrition Assessment (total of patient and medical staff)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Among patients undergoing curative treatment for kidney cancer, prostate cancer, or bladder cancer, patients who score 14 or less on the Geriatric-8 simple geriatric functional assessment tool and who have a reduced food intake in question 1 (by only targeting patients who have a reduced food intake in question 1, we guarantee that the prescription of Rikkunshito will be covered by insurance) will be asked to take Tsumura Rikkunshito for one month before surgery, and we will examine whether their preoperative nutritional status has improved.
Study subjects will be given 7.5g of Tsumura Rikkunshito orally three times a day, before or between meals.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients aged 65 years or older who scored 14 points or less on the Geriatric-8 simple tool for evaluating geriatric function
Patients who responded to question 1 of the Geriatric-8 simple tool for evaluating geriatric function that they had decreased their food intake
Patients scheduled to undergo radical or partial resection for kidney, prostate, or bladder cancer
Patients who understand the contents of the informed consent document and can sign it of their own free will

Key exclusion criteria

Pregnant and breastfeeding patients
Patients who have been confirmed to refuse to participate
Patients with dementia (PS2 or higher)
Patients who regularly visit or are hospitalized in a psychiatric and neurological department due to a psychiatric illness and are deemed to have difficulty participating in the study
Patients who are otherwise deemed ineligible by the principal investigator and co-investigators of this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Tamada

Organization

Bell Land General Hospital

Division name

Urology

Zip code

599-8247

Address

500-3, Higashiyama, Naka-ku, Sakai City, Osaka

TEL

072-234-2001

Email

gambaosakars@yahoo.co.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Tamada

Organization

Bell Land General Hospital

Division name

Urology

Zip code

599-8247

Address

500-3, Higashiyama, Naka-ku, Sakai City, Osaka

TEL

072-234-2001

Homepage URL


Email

irb@bh.seichokai.or.jp


Sponsor or person

Institute

Bell Land General Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Bell Land General Hospital

Address

500-3, Higashiyama, Naka-ku, Sakai City, Osaka

Tel

072-234-2001

Email

irb@bh.seichokai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 03 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 03 Month 01 Day

Date of IRB

2025 Year 02 Month 28 Day

Anticipated trial start date

2025 Year 03 Month 11 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 03 Month 11 Day

Last modified on

2025 Year 09 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065354